FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2147861878> ?p ?o ?g. }

• W2147861878 endingPage "242" @default.
• W2147861878 startingPage "235" @default.
• W2147861878 abstract "The effects of co-administration of the antiepileptic agent valproic acid (VPA) and the non-steroidal anti-inflammatory drug naproxen (NAP) on their relative dispositions (particularly with respect to glucuronidation) were investigated in human volunteers. Seven healthy males received each drug alone and then in combination (orally twice daily for seven days, 500 mg sodium VPA, 500 mg NAP). On day 7 of each dosing phase, serial plasma and 24 h urine samples were collected for analysis. Co-administration of NAP resulted in significant increases (about 20%, p<0.05) in the apparent plasma clearance of total VPA and in the unbound fraction of VPA in plasma, with the apparent plasma clearance of unbound VPA being unchanged. There were associated increases in the formation clearances to urinary VPA-glucuronide and 3-oxo-VPA, though these were relatively greater for the glucuronidation pathway (and remained significant when formation clearances were calculated using the unbound fraction of drug in plasma). The data thus point to a shift towards glucuronidation as a result of the NAP-induced increase in the unbound fraction of VPA in plasma. By contrast, VPA co-administration caused a decrease (of about 10%, p<0.05) in the apparent plasma clearance of total NAP. Taken in hand with in vitro results showing a VPA-induced displacement (of about 40%) of NAP from plasma protein binding sites, the data strongly support a role for diminished glucuronidation of NAP and its desmethyl metabolite in the presence of co-administered VPA." @default.
• W2147861878 created "2016-06-24" @default.
• W2147861878 creator A5045854911 @default.
• W2147861878 creator A5050833432 @default.
• W2147861878 creator A5052099914 @default.
• W2147861878 creator A5074935613 @default.
• W2147861878 creator A5077856680 @default.
• W2147861878 date "2000-09-01" @default.
• W2147861878 modified "2023-09-26" @default.
• W2147861878 title "Effect of naproxen co-administration on valproate disposition" @default.
• W2147861878 cites W1658070542 @default.
• W2147861878 cites W1971465833 @default.
• W2147861878 cites W1979404580 @default.
• W2147861878 cites W1981376669 @default.
• W2147861878 cites W2015075315 @default.
• W2147861878 cites W2023410967 @default.
• W2147861878 cites W2025801868 @default.
• W2147861878 cites W2043818223 @default.
• W2147861878 cites W2047006594 @default.
• W2147861878 cites W2061510537 @default.
• W2147861878 cites W2066847606 @default.
• W2147861878 cites W2068447600 @default.
• W2147861878 cites W2086706082 @default.
• W2147861878 cites W2087072062 @default.
• W2147861878 cites W2123393255 @default.
• W2147861878 cites W2130727601 @default.
• W2147861878 cites W2155021283 @default.
• W2147861878 cites W2162599155 @default.
• W2147861878 cites W2412032634 @default.
• W2147861878 doi "https://doi.org/10.1002/bdd.235" @default.
• W2147861878 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11304722" @default.
• W2147861878 hasPublicationYear "2000" @default.
• W2147861878 type Work @default.
• W2147861878 sameAs 2147861878 @default.
• W2147861878 citedByCount "19" @default.
• W2147861878 countsByYear W21478618782012 @default.
• W2147861878 countsByYear W21478618782016 @default.
• W2147861878 countsByYear W21478618782017 @default.
• W2147861878 countsByYear W21478618782020 @default.
• W2147861878 countsByYear W21478618782021 @default.
• W2147861878 countsByYear W21478618782022 @default.
• W2147861878 countsByYear W21478618782023 @default.
• W2147861878 crossrefType "journal-article" @default.
• W2147861878 hasAuthorship W2147861878A5045854911 @default.
• W2147861878 hasAuthorship W2147861878A5050833432 @default.
• W2147861878 hasAuthorship W2147861878A5052099914 @default.
• W2147861878 hasAuthorship W2147861878A5074935613 @default.
• W2147861878 hasAuthorship W2147861878A5077856680 @default.
• W2147861878 hasConcept C107513589 @default.
• W2147861878 hasConcept C112705442 @default.
• W2147861878 hasConcept C118552586 @default.
• W2147861878 hasConcept C134018914 @default.
• W2147861878 hasConcept C139254425 @default.
• W2147861878 hasConcept C142724271 @default.
• W2147861878 hasConcept C169760540 @default.
• W2147861878 hasConcept C185592680 @default.
• W2147861878 hasConcept C202751555 @default.
• W2147861878 hasConcept C204787440 @default.
• W2147861878 hasConcept C2775858608 @default.
• W2147861878 hasConcept C2777056448 @default.
• W2147861878 hasConcept C2777172819 @default.
• W2147861878 hasConcept C2777477808 @default.
• W2147861878 hasConcept C2778115740 @default.
• W2147861878 hasConcept C2778186239 @default.
• W2147861878 hasConcept C2779186261 @default.
• W2147861878 hasConcept C2779907587 @default.
• W2147861878 hasConcept C2781233306 @default.
• W2147861878 hasConcept C2909752691 @default.
• W2147861878 hasConcept C55493867 @default.
• W2147861878 hasConcept C71924100 @default.
• W2147861878 hasConcept C86803240 @default.
• W2147861878 hasConcept C87644729 @default.
• W2147861878 hasConcept C97320921 @default.
• W2147861878 hasConcept C98274493 @default.
• W2147861878 hasConceptScore W2147861878C107513589 @default.
• W2147861878 hasConceptScore W2147861878C112705442 @default.
• W2147861878 hasConceptScore W2147861878C118552586 @default.
• W2147861878 hasConceptScore W2147861878C134018914 @default.
• W2147861878 hasConceptScore W2147861878C139254425 @default.
• W2147861878 hasConceptScore W2147861878C142724271 @default.
• W2147861878 hasConceptScore W2147861878C169760540 @default.
• W2147861878 hasConceptScore W2147861878C185592680 @default.
• W2147861878 hasConceptScore W2147861878C202751555 @default.
• W2147861878 hasConceptScore W2147861878C204787440 @default.
• W2147861878 hasConceptScore W2147861878C2775858608 @default.
• W2147861878 hasConceptScore W2147861878C2777056448 @default.
• W2147861878 hasConceptScore W2147861878C2777172819 @default.
• W2147861878 hasConceptScore W2147861878C2777477808 @default.
• W2147861878 hasConceptScore W2147861878C2778115740 @default.
• W2147861878 hasConceptScore W2147861878C2778186239 @default.
• W2147861878 hasConceptScore W2147861878C2779186261 @default.
• W2147861878 hasConceptScore W2147861878C2779907587 @default.
• W2147861878 hasConceptScore W2147861878C2781233306 @default.
• W2147861878 hasConceptScore W2147861878C2909752691 @default.
• W2147861878 hasConceptScore W2147861878C55493867 @default.
• W2147861878 hasConceptScore W2147861878C71924100 @default.
• W2147861878 hasConceptScore W2147861878C86803240 @default.
• W2147861878 hasConceptScore W2147861878C87644729 @default.

• next